\-\ Texto\\:\\ \ \(0\)\
\-\ mild\\ wheezes\\ bilaterally\\ in\\ upper\\ lung\\ fields\\,\\ otherwise\\ unremarkable\\ with\\ normal\\ respirator\\ effort\\.\\ sputum\\,\\ blood\\ cultures\\ were\\ negative\\.\\ tb\\ testing\\ negative\\ x\\ 2\\.\ \(0\)\
\-\ 2\\ week\\ follow\\ up\\ with\\ hrct\\ before\\ then\\ to\\ further\\ evaluate\\.\\ no\\ further\\ treatment\\ as\\ patient\\ has\\ completed\\ antibiotic\\ course\\,\\ lesions\\ were\\ determined\\ to\\ be\\ cystic\\ and\\ is\\ asymptomatic\\.\ \(0\)\
\-\ residual\\ pneumonic\\ process\\.\\ lul\\ w\\/\\ multiple\\ cavitations\\.\\ \ \(0\)\
\-\ homogenous\\ mass\\ 3\\.5cm\\ x\\ 4\\.0cm\\ along\\ mid\\ left\\ lateral\\ chest\\ wall\\.\\ \ \(0\)\
\-\ single\\ cavitation\\ 4cm\\ in\\ diameter\\ present\\ in\\ rul\\.\\ \ \(0\)\
\-\ no\\ pleural\\ effusion\\.\\ normal\\ heart\\ size\\.\ \(0\)\
\-\ post\\ inflammatory\\ cystic\\ changes\\ secondary\\ to\\ severe\\ community\\ acquired\\ pneumonia\\.\ \(0\)\
\-\ cystic\\ vs\\.\\ granulomatous\\ lesions\\.\ \(0\)\
\-\ cystic\\:\\ blebs\\,\\ bullae\\,\\ congenital\\ cystic\\ lesions\\,\\ coccidomycosis\\,\\ pcp\\,\\ hydadid\\,\\ traumatic\\ cysts\\.\ \(0\)\
\-\ cavitary\\:\\ neoplastic\\,\\ staph\\,\\ gnr\\,\\ mycobacteria\\,\\ anerobes\\,\\ coccy\\,\\ histo\\,\\ pcp\\,\\ aspergillosis\\,\\ parasites\\,\\ immunologic\\,\\ emboli\\,\\ pmf\\,\\ bronchiectasis\\,\\ congenital\\ lesions\ \(0\)\
\-\ 18\\ yo\\ 6\\ weeks\\ s\\/p\\ acute\\ episode\\ of\\ severe\\ community\\ acquired\\ pneumonia\\ treated\\ with\\ full\\ course\\ of\\ antibiotics\\.\\ patient\\ reported\\ improved\\ symptoms\\ at\\ time\\ of\\ study\\.\ \(0\)\
\-\ 2\\ week\\ follow\\ up\\ with\\ hrct\\ before\\ then\\ to\\ further\\ evaluate\\.\\ no\\ further\\ treatment\\ as\\ patient\\ has\\ completed\\ antibiotic\\ course\\,\\ lesions\\ were\\ determined\\ to\\ be\\ cystic\\ and\\ is\\ asymptomatic\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cystic\\:\\ 0\\.06543272674119713\ \(0\)\
\-\ hrct\\:\\ 0\\.057636578150198695\ \(0\)\
\-\ community\\:\\ 0\\.0553147705000439\ \(0\)\
\-\ lesions\\:\\ 0\\.05060974571557406\ \(0\)\
\-\ further\\:\\ 0\\.048096356492039964\ \(0\)\
\-\ pcp\\:\\ 0\\.047914345507118074\ \(0\)\
\-\ completed\\:\\ 0\\.043572549786335145\ \(0\)\
\-\ course\\:\\ 0\\.04280351473613683\ \(0\)\
\-\ acquired\\:\\ 0\\.04054346831300211\ \(0\)\
\-\ determined\\:\\ 0\\.039458492011300056\ \(0\)\
\-\ respirator\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ coccidomycosis\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ hydadid\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ coccy\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ pmf\\:\\ 0\\.03900671869011725\ \(0\)\
\-\ antibiotic\\:\\ 0\\.03869793953518745\ \(0\)\
\-\ 4\\.0cm\\:\\ 0\\.03593969576728563\ \(0\)\
\-\ gnr\\:\\ 0\\.03593969576728563\ \(0\)\
\-\ anerobes\\:\\ 0\\.03593969576728563\ \(0\)\
\-\ pneumonic\\:\\ 0\\.03414560236857694\ \(0\)\
\-\ before\\:\\ 0\\.03200903887345728\ \(0\)\
\-\ cavitations\\:\\ 0\\.03188531199793097\ \(0\)\
\-\ 3\\.5cm\\:\\ 0\\.03188531199793097\ \(0\)\
\-\ parasites\\:\\ 0\\.03188531199793097\ \(0\)\
\-\ immunologic\\:\\ 0\\.03188531199793097\ \(0\)\
\-\ pneumonia\\:\\ 0\\.03125942208166823\ \(0\)\
\-\ blebs\\:\\ 0\\.03107857944574532\ \(0\)\
\-\ mycobacteria\\:\\ 0\\.03107857944574532\ \(0\)\
\-\ evaluate\\:\\ 0\\.03056837396687675\ \(0\)\
\-\ histo\\:\\ 0\\.03039649679164241\ \(0\)\
\-\ \\,\\:\\ 0\\.028747971559357953\ \(0\)\
\-\ bullae\\:\\ 0\\.028396562615788174\ \(0\)\
\-\ staph\\:\\ 0\\.028396562615788174\ \(0\)\
\-\ lul\\:\\ 0\\.02765738525002195\ \(0\)\
\-\ cavitation\\:\\ 0\\.02765738525002195\ \(0\)\
\-\ congenital\\:\\ 0\\.027656274067632193\ \(0\)\
\-\ then\\:\\ 0\\.02691121131346982\ \(0\)\
\-\ rul\\:\\ 0\\.02673862699879078\ \(0\)\
\-\ aspergillosis\\:\\ 0\\.02647037645978001\ \(0\)\
\-\ were\\:\\ 0\\.02575601331889276\ \(0\)\
\-\ week\\:\\ 0\\.025681552374586088\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.02556276458403617\ \(0\)\
\-\ effort\\:\\ 0\\.0255353804701021\ \(0\)\
\-\ x\\:\\ 0\\.024947489693340506\ \(0\)\
\-\ 2\\:\\ 0\\.024426165882883356\ \(0\)\
\-\ 4cm\\:\\ 0\\.024423369725496323\ \(0\)\
\-\ sputum\\:\\ 0\\.024107179619380636\ \(0\)\
\-\ follow\\:\\ 0\\.02402831391103039\ \(0\)\
\-\ cavitary\\:\\ 0\\.023535446294247864\ \(0\)\
\-\ severe\\:\\ 0\\.02326822831916818\ \(0\)\
\-\ wheezes\\:\\ 0\\.022796268928481647\ \(0\)\
\-\ negative\\:\\ 0\\.022585134171459065\ \(0\)\
\-\ homogenous\\:\\ 0\\.022468357547270484\ \(0\)\
\-\ bronchiectasis\\:\\ 0\\.02206582755520975\ \(0\)\
\-\ fields\\:\\ 0\\.02060458115312755\ \(0\)\
\-\ emboli\\:\\ 0\\.020468423371416248\ \(0\)\
\-\ up\\:\\ 0\\.020334930540302863\ \(0\)\
\-\ w\\/\\:\\ 0\\.019617220306604496\ \(0\)\
\-\ cultures\\:\\ 0\\.019454326620220796\ \(0\)\
\-\ neoplastic\\:\\ 0\\.019348969767593725\ \(0\)\
\-\ residual\\:\\ 0\\.018764634714438563\ \(0\)\
\-\ episode\\:\\ 0\\.018719251970335957\ \(0\)\
\-\ testing\\:\\ 0\\.01828932387983309\ \(0\)\
\-\ granulomatous\\:\\ 0\\.01824854222007679\ \(0\)\
\-\ tb\\:\\ 0\\.018208133000770274\ \(0\)\
\-\ improved\\:\\ 0\\.01801144378585508\ \(0\)\
\-\ 18\\:\\ 0\\.016414039602061583\ \(0\)\
\-\ full\\:\\ 0\\.016334311701607252\ \(0\)\
\-\ diameter\\:\\ 0\\.01590779911012466\ \(0\)\
\-\ s\\/p\\:\\ 0\\.015860220385450936\ \(0\)\
\-\ traumatic\\:\\ 0\\.015836621509453756\ \(0\)\
\-\ mid\\:\\ 0\\.015813147827021486\ \(0\)\
\-\ single\\:\\ 0\\.015325930488895715\ \(0\)\
\-\ treatment\\:\\ 0\\.015306344775229089\ \(0\)\
\-\ vs\\:\\ 0\\.014887079515047778\ \(0\)\
\-\ cysts\\:\\ 0\\.014811762313413128\ \(0\)\
\-\ pleural\\:\\ 0\\.014682965480855292\ \(0\)\
\-\ process\\:\\ 0\\.01455781187979962\ \(0\)\
\-\ effusion\\:\\ 0\\.014368026195599121\ \(0\)\
\-\ antibiotics\\:\\ 0\\.014202284768453545\ \(0\)\
\-\ has\\:\\ 0\\.014200884694639627\ \(0\)\
\-\ reported\\:\\ 0\\.01378351703794607\ \(0\)\
\-\ otherwise\\:\\ 0\\.013581040855868783\ \(0\)\
\-\ heart\\:\\ 0\\.013137520570392806\ \(0\)\
\-\ inflammatory\\:\\ 0\\.013112017452177096\ \(0\)\
\-\ size\\:\\ 0\\.012676441908755626\ \(0\)\
\-\ unremarkable\\:\\ 0\\.012517993003017968\ \(0\)\
\-\ along\\:\\ 0\\.012495813614418212\ \(0\)\
\-\ study\\:\\ 0\\.01244084671176973\ \(0\)\
\-\ bilaterally\\:\\ 0\\.012419049727981872\ \(0\)\
\-\ post\\:\\ 0\\.011906349703859707\ \(0\)\
\-\ normal\\:\\ 0\\.011854977474328328\ \(0\)\
\-\ be\\:\\ 0\\.011661563923397603\ \(0\)\
\-\ as\\:\\ 0\\.011438738990213521\ \(0\)\
\-\ no\\:\\ 0\\.011421825009342504\ \(0\)\
\-\ yo\\:\\ 0\\.011377661607534345\ \(0\)\
\-\ patient\\:\\ 0\\.011370689348447628\ \(0\)\
\-\ treated\\:\\ 0\\.011317924053468403\ \(0\)\
\-\ 6\\:\\ 0\\.011292567085729533\ \(0\)\
\-\ lung\\:\\ 0\\.010952031505481177\ \(0\)\
\-\ wall\\:\\ 0\\.010952031505481177\ \(0\)\
\-\ changes\\:\\ 0\\.01083649547006664\ \(0\)\
\-\ weeks\\:\\ 0\\.01073131750841216\ \(0\)\
\-\ time\\:\\ 0\\.01067965144796156\ \(0\)\
\-\ secondary\\:\\ 0\\.010570929055348706\ \(0\)\
\-\ blood\\:\\ 0\\.010320402975704865\ \(0\)\
\-\ \\:\\:\\ 0\\.01000243199991739\ \(0\)\
\-\ mild\\:\\ 0\\.009956873689960783\ \(0\)\
\-\ to\\:\\ 0\\.00944840947882713\ \(0\)\
\-\ symptoms\\:\\ 0\\.00942326317211566\ \(0\)\
\-\ acute\\:\\ 0\\.00933574924383405\ \(0\)\
\-\ upper\\:\\ 0\\.00912425002375539\ \(0\)\
\-\ chest\\:\\ 0\\.00904747345158194\ \(0\)\
\-\ present\\:\\ 0\\.008539861743060534\ \(0\)\
\-\ lateral\\:\\ 0\\.008171097547011284\ \(0\)\
\-\ multiple\\:\\ 0\\.007963743378226853\ \(0\)\
\-\ in\\:\\ 0\\.0055937685416848\ \(0\)\
\-\ mass\\:\\ 0\\.005258677021891879\ \(0\)\
\-\ at\\:\\ 0\\.005122845808989526\ \(0\)\
\-\ is\\:\\ 0\\.004976024587475448\ \(0\)\
\-\ left\\:\\ 0\\.004230554288818206\ \(0\)\
\-\ \\.\\:\\ 0\\.0029844742736707046\ \(0\)\
\-\ with\\:\\ 0\\.0020708703732723846\ \(0\)\
\-\ and\\:\\ 0\\.0015930000507275968\ \(0\)\
\-\ of\\:\\ 0\\.0015465106300617934\ \(0\)\
